October 12, 2016
Takeda Pharmaceutical and Crescendo Biologics have inked a collaboration and licensing pact worth up to US$790 million to discover and develop cancer treatments based on the UK startup’s Humabody technology, the two companies said on October 10. The global collaboration...read more